BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28668223)

  • 1. An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy.
    Bonam SR; Partidos CD; Halmuthur SKM; Muller S
    Trends Pharmacol Sci; 2017 Sep; 38(9):771-793. PubMed ID: 28668223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of adjuvants utilized in prophylactic vaccine formulation as immunomodulators.
    Chauhan N; Tiwari S; Iype T; Jain U
    Expert Rev Vaccines; 2017 May; 16(5):491-502. PubMed ID: 28285554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulant properties of chemical delivery systems in vaccine development.
    Hosseinzadeh S; Bolhassani A
    Curr Drug Deliv; 2015; 12(4):360-8. PubMed ID: 25751632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Communicating the role and value of vaccine adjuvants.
    Gellin BG; Salisbury DM
    Vaccine; 2015 Jun; 33 Suppl 2():B44-6. PubMed ID: 26022567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in vaccine adjuvants.
    Schijns VE; Lavelle EC
    Expert Rev Vaccines; 2011 Apr; 10(4):539-50. PubMed ID: 21506650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oil-based emulsion vaccine adjuvants.
    Schijns VEJC; Strioga M; Ascarateil S
    Curr Protoc Immunol; 2014 Aug; 106():2.18.1-2.18.7. PubMed ID: 25081910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic adjuvants for vaccine formulations: phytol derivatives.
    Ghosh SK; Chowdhury RR
    Expert Opin Drug Deliv; 2013 Apr; 10(4):437-50. PubMed ID: 23293963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems analysis of human vaccine adjuvants.
    Harandi AM
    Semin Immunol; 2018 Oct; 39():30-34. PubMed ID: 30122362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity.
    Marciani DJ
    Drug Discov Today; 2003 Oct; 8(20):934-43. PubMed ID: 14554157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination adjuvants: the next generation of adjuvants?
    Mutwiri G; Gerdts V; van Drunen Littel-van den Hurk S; Auray G; Eng N; Garlapati S; Babiuk LA; Potter A
    Expert Rev Vaccines; 2011 Jan; 10(1):95-107. PubMed ID: 21162624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical and functional characterization of vaccine antigens and adjuvants.
    Dey AK; Malyala P; Singh M
    Expert Rev Vaccines; 2014 May; 13(5):671-85. PubMed ID: 24702271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbohydrate-based vaccine adjuvants - discovery and development.
    Hu J; Qiu L; Wang X; Zou X; Lu M; Yin J
    Expert Opin Drug Discov; 2015 Oct; 10(10):1133-44. PubMed ID: 26372693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability.
    Clapp T; Siebert P; Chen D; Jones Braun L
    J Pharm Sci; 2011 Feb; 100(2):388-401. PubMed ID: 20740674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvants for human vaccines--current status, problems and future prospects.
    Gupta RK; Siber GR
    Vaccine; 1995 Oct; 13(14):1263-76. PubMed ID: 8585280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular adjuvants for malaria DNA vaccines based on the modulation of host-cell apoptosis.
    Bergmann-Leitner ES; Leitner WW; Duncan EH; Savranskaya T; Angov E
    Vaccine; 2009 Sep; 27(41):5700-8. PubMed ID: 19576940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Vaccine Adjuvants: Nanomaterials and Small Molecules.
    Sun B; Li M; Yao Z; Yu G; Ma Y
    Handb Exp Pharmacol; 2024; 284():113-132. PubMed ID: 37059911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
    Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory properties of vitamins, flavonoids and plant oils and their potential as vaccine adjuvants and delivery systems.
    Vajdy M
    Expert Opin Biol Ther; 2011 Nov; 11(11):1501-13. PubMed ID: 21955085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
    Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
    Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid and carbohydrate based adjuvant/carriers in immunology.
    McGeary RP; Olive C; Toth I
    J Pept Sci; 2003 Jul; 9(7):405-18. PubMed ID: 12916638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.